The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial
PURPOSENephrotoxicity is a major dose-limiting toxicity among patients with cancer who were treated with cisplatin. Although no standard approach is available to prevent cisplatin-induced nephrotoxicity, administering intravenous isotonic saline is recommended. Additionally, mannitol combined with h...
Main Authors: | Panot Sainamthip, Siriwimon Saichaemchan, Bancha Satirapoj, Naiyarat Prasongsook |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2022-03-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO.21.00275 |
Similar Items
-
Impact of interprofessional collaborative practice in palliative care on outcomes for advanced cancer inpatients in a resource-limited setting
by: Pitchayapa Pornrattanakavee, et al.
Published: (2022-12-01) -
Curcumin supplementation prevents cisplatin-induced nephrotoxicity: a randomized, double-blinded, and placebo-controlled trial
by: Hasan Mehrab, et al.
Published: (2023-01-01) -
Efficacy and safety of intravenous 3% hypertonic saline compared to mannitol 20% for lowering intraocular pressure in patients with glaucoma: A prospective randomized double-blind study
by: Ashraf A H. Mhmoud, et al.
Published: (2020-01-01) -
Protective effect of selenium on cisplatin induced nephrotoxicity: A double-blind controlled randomized clinical trial
by: Ali Ghorbani, et al.
Published: (2013-04-01) -
Role of probiotics in the management of cisplatin-induced nephrotoxicity
by: Serina Easmin, et al.
Published: (2024-03-01)